
    
      An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose,
      crossover, oral bioequivalence study of Guaifenesin and Pseudoephedrine Hydrochloride
      Extended Release Tablets 1200/120 mg of Dr. Reddy's Laboratories Ltd., India comparing with
      Mucinex D (Guaifenesin and Pseudoephedrine Hydrochloride) extended-release bi-layer tablets
      1200/120 mg of Reckitt Benckiser Inc., USA in healthy, adult, human subjects under fasting
      conditions.
    
  